(Q34222223)

31 July 2017

The bactericidal activity of moxifloxacin in patients with pulmonary tuberculosis (English)

1 reference

31 July 2017

0 references

0 references

1 reference

pulmonary tuberculosis

1 reference

Richard W Morris

7

0 references

Esther G Kanduma

object named as

Esther G Kanduma

5

1 reference

ORCID Public Data File 2021

author name string

Roly D Gosling

1

1 reference

31 July 2017

Leonard O Uiso

2

1 reference

31 July 2017

Noel E Sam

3

1 reference

31 July 2017

Emily Bongard

4

1 reference

31 July 2017

Mramba Nyindo

6

1 reference

31 July 2017

Stephen H Gillespie

8

1 reference

31 July 2017

language of work or name

English

0 references

publication date

13 August 2003

1 reference

American Journal of Respiratory and Critical Care Medicine

31 July 2017

1 reference

31 July 2017

168

1 reference

31 July 2017

1342-1345

1 reference

31 July 2017

11

1 reference

Whither short-course chemotherapy?

31 July 2017

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200305-682OC

Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200305-682OC

Activity of moxifloxacin against mycobacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200305-682OC

In vitro and in vivo activities of levofloxacin against Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200305-682OC

In vitro activity of four fluoroquinolones against Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200305-682OC

Moxifloxacin (BAY12-8039), a new 8-methoxyquinolone, is active in a mouse model of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200305-682OC

Safety profile of ciprofloxacin during long-term therapy for pulmonary tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200305-682OC

Randomized controlled trial of a drug regimen that includes ciprofloxacin for the treatment of pulmonary tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200305-682OC

A reiterative method for calculating the early bactericidal activity of antituberculosis drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200305-682OC

The early bactericidal activity of isoniazid related to its dose size in pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200305-682OC

The early bactericidal activity of rifabutin in patients with pulmonary tuberculosis measured by sputum viable counts: a new method of drug assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200305-682OC

A multicentre study of the early bactericidal activity of anti-tuberculosis drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200305-682OC

The early bactericidal activity of ciprofloxacin in patients with pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200305-682OC

Bactericidal and sterilizing activities of antituberculosis drugs during the first 14 days

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200305-682OC

Early bactericidal and sterilizing activities of ciprofloxacin in pulmonary tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200305-682OC

Studies of the early bactericidal activity of new drugs for tuberculosis: a help or a hindrance to antituberculosis drug development?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200305-682OC

The early bactericidal activity of rifabutin measured by sputum viable counts in Hong Kong patients with pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200305-682OC

10.1164/RCCM.200305-682OC

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference